Serum Iron, Zinc, and Copper Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analyses.
Level 3 - non-randomized controlled study
Meta-analysis of observational case-control studies combined with an observational replication study
PubMed 26401693 · doi:10.3233/JAD-143108
What was done
The authors conducted meta-analyses of literature published between 1984 and 2014 alongside an empirical replication study to evaluate serum iron, zinc, and copper concentrations in patients with Alzheimer's disease (AD) versus healthy controls. Meta-regression analyses were performed to evaluate potential confounding by age, sex ratio, and methodological variables.
What was found
The abstract provides no numerical data, effect sizes, confidence intervals, or sample sizes. Qualitatively, serum zinc was significantly lower and serum copper was significantly higher in AD patients compared to controls. Serum iron showed no significant change, though the finding was not robust. Meta-regression suggested differences in mean age accounted for some iron variability, and sex ratio had a subtle effect on zinc levels, while high heterogeneity in copper findings remained unexplained.
Why it matters
The findings synthesize three decades of research supporting an association between elevated peripheral copper, decreased zinc, and Alzheimer's disease. They emphasize the necessity of adjusting for demographic covariates like age and sex in trace element research.
Limits
The abstract reports zero numerical metrics, study counts, or participant numbers. Because the synthesis comprises observational case-control data, causality cannot be established. Substantial heterogeneity in copper measurements remained unexplained by evaluated variables.
Cited by
- supports Literature from over 30 years ago documented that individuals with elevated copper-to-zinc ratios have a higher incidence of dementia.